期刊簡介 | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | Frontiers in Aging Neuroscience LetPub Score 7.5
50 ratings
Rate
Reputation 8.3 Influence 6.5 Speed 8.9 | ||||||||||||||||||||
期刊簡稱 | FRONT AGING NEUROSCI | ||||||||||||||||||||
ISSN | 1663-4365 | ||||||||||||||||||||
h-index | 55 | ||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||
自引率 (2023-2024) | 4.90%自引率趨勢 | ||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||
官方網站 | http://journal.frontiersin.org/journal/aging-neuroscience | ||||||||||||||||||||
在線稿件提交 | http://www.frontiersin.org/submission/submissioninfo.aspx | ||||||||||||||||||||
開放訪問 | Yes | ||||||||||||||||||||
出版商 | Frontiers Media S.A. | ||||||||||||||||||||
主題領域 | GERIATRICS & GERONTOLOGY | ||||||||||||||||||||
出版國/地區 | SWITZERLAND | ||||||||||||||||||||
發行頻率 | |||||||||||||||||||||
創刊年 | 0 | ||||||||||||||||||||
每年文章數 | 781每年文章數趨勢 | ||||||||||||||||||||
黃金OA百分比 | 99.57% | ||||||||||||||||||||
OA Related Info | APC: Yes( USD3295; ) APC waiver:Check Notes Other charges: No Keywords: aging neuroscience、neurodegeneration、brain senescense、alzheimer's disease、neural mechanisms Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review | ||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q2
| ||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1663-4365%5BISSN%5D | ||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Invited contributions ? Irregular | ||||||||||||||||||||
競爭力 * | 來自作者的數據: | ||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
首頁 上一頁 1 2 3 4 5 下一頁 末頁 (頁 | |
[Frontiers in Aging Neuroscience] 的評論 | 撰寫評論 |
作者: 艾去西西 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-11-13 16:22:39 評論於 It's really frustrating, it's been a month and the editor still hasn't been assigned.(0) 讚! | 艾去西西 |
作者: 痴云少爷 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-10-29 12:04:19 評論於 I am also the same. How have you been since then, teacher?(0) 讚! | 痴云少爷 |
作者: 若翠公子 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-10-08 20:26:54 評論於 Sorry, my research does not involve WB.(0) 讚! | 若翠公子 |
作者: kiton zhou 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-10-07 22:43:55 評論於 I am also, on the second day of submission (the 4th), he asked me to resubmit or contact the editor, but there was no response after resubmission.(0) 讚! | kiton zhou |
作者: Shirley Rose 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-09-16 18:36:20 評論於 Why have I been submitting for a month already and still can't find an editor?(0) 讚! | Shirley Rose |
作者: 努力啊大丹蝶 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-08-15 14:23:27 評論於 Do you need WB uncut film?(0) 讚! | 努力啊大丹蝶 |
作者: 若翠公子 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-05-28 10:18:52 評論於 Review speed: 2.0 | Submission hit rate: 50.0 Emphasized research direction: Parkinson's; Machine learning experience sharing: Feb 29, 2024 Corresponding Author submitted manuscript. Apr 26, 2024 Review of Reviewer 2 is finalized. May 17, 2024 Interactive review forum activated. (minor revisions) May 19, 2024 Revision submitted. May 24, 2024 Review of Review Editor 3 finalized. May 27, 2024 Article accepted for publication. Note: Reviewer 1 did not provide feedback on the manuscript in March, so the review was withdrawn.(0) 讚! | 若翠公子 |
作者: 墟散寻白 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-05-27 10:11:17 評論於 How have you been since then? I'm doing well too(0) 讚! | 墟散寻白 |
作者: 伶俐小姐姐 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-05-16 13:15:48 評論於 How to contact(0) 讚! | 伶俐小姐姐 |
作者: 珉林弘量 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-05-05 11:54:32 評論於 How much is the layout fee? I am ready to invest(0) 讚! | 珉林弘量 |
作者: 玉景雅之 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-03-25 21:31:27 評論於 Currently, there is a review being considered for publication in this journal, but the supervisor hospital has banned this journal. I cannot afford the high publication fees myself. What should I do?(0) 讚! | 玉景雅之 |
作者: 努力啊大优乐 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-08 20:54:45 評論於 Review speed: 1.0 | Acceptance rate: 75.0 Experience sharing: The review process is quite fast, the reviewers are also very nice, without very tricky questions, and the paper was published after three months(0) 讚! | 努力啊大优乐 |
作者: 烈焰天才 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-07-05 19:51:56 評論於 Editorial Office requested Corresponding/Submitting Author to resubmit their manuscript. If received this message, should I resubmit directly? Do I need to add any materials? The email did not specify any problems that need to be resubmitted(0) 讚! | 烈焰天才 |
作者: 西域羡丽 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-05-16 20:23:34 評論於 Review Speed: 3.0 | Submission Acceptance Rate: 75.0 Research Focus: Stroke; Molecular Epidemiology Experience Sharing: The first paper was from submission to publication in less than 2 months; the second paper took almost 3 months. The reviewers raised quite professional questions, except for citing one of their articles. Overall speed is good, the first paper was really fast, and very pleasant. The second paper was a bit slow, but still relatively fast. Good luck to everyone~(0) 讚! | 西域羡丽 |
作者: 湘灵酱大魔王 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-03-05 14:02:32 評論於 They seem to have not found reviewers for the past few months, so it's very slow(0) 讚! | 湘灵酱大魔王 |
作者: 夜柳酱吖 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-02-21 16:01:48 評論於 At last(0) 讚! | 夜柳酱吖 |
作者: 一吃就胖小香凝 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-02-12 14:03:38 評論於 Review speed: 2.0 | Submission hit rate: 50.0 Emphasized research direction: AD Experience sharing: Submitted a month ago, two reviewers rejected and withdrew two weeks ago, and the editor has not found new reviewers yet, is it stuck?(0) 讚! | 一吃就胖小香凝 |
作者: 破戒丹旋 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-02-03 09:48:16 評論於 The date at the back seems wrong, it should be 2023(0) 讚! | 破戒丹旋 |
作者: 小小风吖 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-02-02 09:07:21 評論於 Review speed: 2.0 | Submission acceptance rate: 75.0 Research focus: Parkinson's Disease Experience sharing: 2022/11/07 Initial Validation; Editorial Assignment 2022/12/13 Independent Review 2022/12/28 Substantial revision 2022/01/08 Revision 2022/01/10 Review 1 Endorsed 2022/01/17 Urgent request, New comments from Review 2 2022/01/19 Revision 2022/01/23 Review 2 Endorsed; Review Finalized 2022/01/23 Accept(0) 讚! | 小小风吖 |
作者: 昕珏小公主 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-01-13 10:31:36 評論於 Dear teachers, may I submit my manuscript to another journal if it has not been assigned to an editor after three weeks of submission? I really don't want to wait any longer(0) 讚! | 昕珏小公主 |
作者: 昕珏小公主 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-01-09 21:13:29 評論於 Is the slow reviewing process of this magazine due to the quality of my submission? It has been several months and there has been no response. Thank you(0) 讚! | 昕珏小公主 |
作者: 稻妻千白 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-01-07 13:35:57 評論於 Hello, I am also experiencing this situation. The signature is indeed Cunming Duan. I have not received the receipt yet. He said to reply to his confirmation email before he sends the payment account. How can I identify whether this email is real or fake?(0) 讚! | 稻妻千白 |
作者: 北海玉梅 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-12-17 19:09:18 評論於 Oh my goodness, I also received an email from this scammer(0) 讚! | 北海玉梅 |
作者: 北海玉梅 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-12-17 08:44:44 評論於 It takes about a month to be searchable in NCBI PubMed after acceptance, and it's likely similar on Web of Science(0) 讚! | 北海玉梅 |
作者: Juliet Melville 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-12-11 15:30:20 評論於 Review Speed: 1.0 | Submission Hit Rate: 25.0 Emphasized Research Areas: Alzheimer's disease; Neurodegenerative disease Experience Sharing: Handling Editor: Sandeep Kumar Singh Received date: 08 Aug 2022 Editorial assignment start date: 09 Aug 2022 Independent review start date: 24 Aug 2022 Interactive review activated date: 03 Sep 2022 Review finalized date: 19 Oct 2022 Final validation date: 10 Nov 2022(0) 讚! | Juliet Melville |
首頁 上一頁 1 2 3 4 5 下一頁 末頁 (頁 |
Contact us